148 related articles for article (PubMed ID: 22103800)
1. Improvement of skin surface texture by topical estradiol treatment in climacteric women.
Masuda Y; Hirao T; Mizunuma H
J Dermatolog Treat; 2013 Aug; 24(4):312-7. PubMed ID: 22103800
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women.
Sator PG; Sator MO; Schmidt JB; Nahavandi H; Radakovic S; Huber JC; Hönigsmann H
Climacteric; 2007 Aug; 10(4):320-34. PubMed ID: 17653959
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms.
Mizunuma H
Climacteric; 2011 Oct; 14(5):581-9. PubMed ID: 21848497
[TBL] [Abstract][Full Text] [Related]
5. Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators.
Verdier-Sévrain S
Climacteric; 2007 Aug; 10(4):289-97. PubMed ID: 17653955
[TBL] [Abstract][Full Text] [Related]
6. [Low-dose estrogens in the treatment of the climacteric syndrome].
Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M
Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038
[TBL] [Abstract][Full Text] [Related]
7. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
[TBL] [Abstract][Full Text] [Related]
8. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality.
Genazzani AR; Stomati M; Valentino V; Pluchino N; Pot E; Casarosa E; Merlini S; Giannini A; Luisi M
Climacteric; 2011 Dec; 14(6):661-8. PubMed ID: 21942655
[TBL] [Abstract][Full Text] [Related]
9. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
[TBL] [Abstract][Full Text] [Related]
10. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.
Phillips TJ; Symons J; Menon S;
J Am Acad Dermatol; 2008 Sep; 59(3):397-404.e3. PubMed ID: 18625536
[TBL] [Abstract][Full Text] [Related]
11. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR
Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
[TBL] [Abstract][Full Text] [Related]
12. [Topical hormonal treatment and urogenital atrophy].
Sitruk-Ware R; Thomas JL
Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
[TBL] [Abstract][Full Text] [Related]
13. [Low dose estrogens and synthetic estrogens. Options for hormone replacement therapy in climacteric women].
Velasco-Murillo V
Rev Med Inst Mex Seguro Soc; 2007; 45(4):381-7. PubMed ID: 17949576
[TBL] [Abstract][Full Text] [Related]
14. [Percutaneous estrogen therapy in the post-menopausal period].
Keller PJ
Schweiz Med Wochenschr; 1989 Jul; 119(29):999-1004. PubMed ID: 2678438
[TBL] [Abstract][Full Text] [Related]
15. [Transdermal administration of estrogens in women with the postcastration and climacteric syndromes].
Rotta L; Matĕchová E
Cesk Gynekol; 1992 Sep; 57(7):336-40. PubMed ID: 1394497
[TBL] [Abstract][Full Text] [Related]
16. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
17. Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study.
Farish E; Barnes JF; Rankin M; Hart DM
Climacteric; 2003 Sep; 6(3):211-20. PubMed ID: 14567769
[TBL] [Abstract][Full Text] [Related]
18. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
Pitkin J; Smetnik VP; Vadász P; Mustonen M; Salminen K; Ylikangas S;
Menopause Int; 2007 Sep; 13(3):116-23. PubMed ID: 17785037
[TBL] [Abstract][Full Text] [Related]
19. Effect of hormonal replacement therapy on skin biophysical properties of menopausal women.
Guinot C; Malvy D; Ambroisine L; Latreille J; Mauger E; Guéhenneux S; Morizot F; Tschachler E
Skin Res Technol; 2005 Aug; 11(3):201-4. PubMed ID: 15998332
[TBL] [Abstract][Full Text] [Related]
20. Induction of collagen by estradiol: difference between sun-protected and photodamaged human skin in vivo.
Rittié L; Kang S; Voorhees JJ; Fisher GJ
Arch Dermatol; 2008 Sep; 144(9):1129-40. PubMed ID: 18794456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
